SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 75 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,684 | -11.0% | 34,138 | +28.2% | 0.00% | – |
| Q2 2023 | $557,157 | +22.1% | 26,620 | +23.2% | 0.00% | – |
| Q1 2023 | $456,403 | -12.7% | 21,610 | +5.2% | 0.00% | – |
| Q4 2022 | $523,023 | +8.6% | 20,551 | +2.6% | 0.00% | – |
| Q3 2022 | $481,417 | +22.4% | 20,034 | -2.0% | 0.00% | – |
| Q2 2022 | $393,169 | +17.2% | 20,435 | +5.9% | 0.00% | – |
| Q1 2022 | $335,382 | -34.1% | 19,297 | -17.0% | 0.00% | – |
| Q4 2021 | $509,000 | +11.6% | 23,256 | -2.6% | 0.00% | – |
| Q3 2021 | $456,000 | +3.9% | 23,884 | -6.6% | 0.00% | – |
| Q2 2021 | $439,000 | +8.9% | 25,570 | +42.0% | 0.00% | – |
| Q1 2021 | $403,000 | +8.9% | 18,007 | +8.2% | 0.00% | – |
| Q4 2020 | $370,000 | +52.9% | 16,637 | +1.5% | 0.00% | – |
| Q3 2020 | $242,000 | +2.1% | 16,391 | 0.0% | 0.00% | – |
| Q2 2020 | $237,000 | +50.0% | 16,391 | +13.6% | 0.00% | – |
| Q1 2020 | $158,000 | +36.2% | 14,435 | +9.2% | 0.00% | – |
| Q4 2019 | $116,000 | +2.7% | 13,214 | -9.6% | 0.00% | – |
| Q3 2019 | $113,000 | -16.9% | 14,621 | 0.0% | 0.00% | – |
| Q2 2019 | $136,000 | +2620.0% | 14,621 | +1922.3% | 0.00% | – |
| Q2 2018 | $5,000 | -96.7% | 723 | -93.2% | 0.00% | – |
| Q1 2018 | $151,000 | +504.0% | 10,566 | +266.9% | 0.00% | – |
| Q4 2017 | $25,000 | +212.5% | 2,880 | +297.8% | 0.00% | – |
| Q3 2017 | $8,000 | +700.0% | 724 | +670.2% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 94 | -3.1% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 97 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 97 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |